Nicholas L. Rider

2.4k citations
64 papers · 954 indexed · h-index 16

Nicholas L. Rider

52 papers receiving 933 citations

Peers

Nicholas L. Rider
Comparison fields: 5 of 108
  • Clinical Biochemistry 164
  • Immunology 486
  • Health Informatics 19
  • Genetics 236
  • Genetics 67
Replace Abdolkarim Moazeni‐Roodi with:
Abdolkarim Moazeni‐Roodi Iran
Dharmesh D. Desai United States
Sílvia Vilarinho United States
Michał Abel France
Petra Heyder Germany
Qian Wu China
Sebastian Boeltz Germany
Parvin Merryman United States
Ichiro Ueno Japan
Jürgen Bux Germany
Nicholas L. Rider relative to Abdolkarim Moazeni‐Roodi Iran Abdolkarim Moazeni‐Roodi's profile →
Citations per field
00.5×4.9×
Abdolkarim Moazeni‐Roodi · 1×
Citations per year

Countries citing papers authored by Nicholas L. Rider

Since Specialization
Citations

This map shows the geographic impact of Nicholas L. Rider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas L. Rider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas L. Rider more than expected).

Fields of papers citing papers by Nicholas L. Rider

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas L. Rider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas L. Rider. The network helps show where Nicholas L. Rider may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nicholas L. Rider, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nicholas L. Rider Line = papers co-authored together Nicholas L. Rider links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20253
3 202415
4 20241
5 20240
6 20240
7 20246
8 20230
9 20231
10 20230
11 20234
12 20211
13 20204
14 20207
15 201827
16 20173
17 201772
18 2010150
19 200933
20 200810

About Nicholas L. Rider

Nicholas L. Rider is a scholar working on Immunology, Immunology and Allergy and Health Informatics, having authored 64 papers that have together received 954 indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (33 papers), Immune Cell Function and Interaction (8 papers), Cystic Fibrosis Research Advances (7 papers), Parvovirus B19 Infection Studies (6 papers), Genomics and Rare Diseases (5 papers), Blood disorders and treatments (5 papers), Food Allergy and Anaphylaxis Research (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Clinical Biochemistry (164 citations), Immunology (486 citations) and Health Informatics (19 citations). Nicholas L. Rider has collaborated with scholars based in United States, United Kingdom and Chile. Frequent co-authors include Kevin A. Strauss, D. Holmes Morton, Erik G. Puffenberger, Christine Hendrickson, Jordan S. Orange, Ann B. Moser, Bridget Wardley, Michael B. Jameson, C. Buddy Creech and Wilfredo Torres‐Martinez. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and PEDIATRICS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026